A multidisciplinary approach, combining MRI features (e.g., “fluid-fluid levels” in ABC) and immunohistochemical markers (p63, CD68, Ki-67), was crucial for accurate differentiation and pathogenic insights. The gene discussed is CD68; the disease is aneurysmal bone cyst.